Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
Azeem T MalikJae BaekJohn H AlexanderRyan T VoskuilSafdar N KhanThomas J ScharschmidtPublished in: Journal of surgical oncology (2020)
The overall prognosis of MFH of bone is poor with a reported 5-year survival rate of 38.3%. Undergoing surgery and younger age were associated with a better prognosis. Older age, having Medicare insurance, and positive surgical margins were predictors of mortality.
Keyphrases
- bone mineral density
- minimally invasive
- soft tissue
- free survival
- bone loss
- coronary artery bypass
- affordable care act
- bone regeneration
- cardiovascular events
- physical activity
- postmenopausal women
- health insurance
- type diabetes
- middle aged
- emergency department
- coronary artery disease
- body composition
- acute coronary syndrome
- atrial fibrillation
- drug induced